Tusa, Ignazia
Cheloni, Giulia
Poteti, Martina
Silvano, Angela
Tubita, Alessandro
Lombardi, Zoe
Gozzini, Antonella
Caporale, Roberto
Scappini, Barbara
Dello Sbarba, Persio
Rovida, Elisabetta http://orcid.org/0000-0002-5949-3239
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (#IG5220, #IG13466, #IG15282, #IG21349, #IG23607)
Istituto Toscano Tumori
Article History
First Online: 11 August 2020
Declarations
:
: This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (Grants IG5220, IG13466, and IG23607 to Persio Dello Sbarba; grants IG15282 and IG21349 to Elisabetta Rovida) and Istituto Toscano Tumori (Persio Dello Sbarba).
: Antonella Gozzini and Barbara Scappini received honoraria from Novartis and Incyte for lectures at conferences on issues outside those of this work. Overall, the authors have no conflict of interest to declare.
: Patient-derived CML cells were collected following informed consent and under approval of the Ethical Committee of AOUC (authorization no. 520/10, October 18, 2010, renewed with no. 2015/0032965, November 4, 2015).
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.